on tirzepatide and gaining weight Why am I tirzepatide? Causes, fixes, what to do next Understanding Why You May Gain

However, its important for individuals considering this treatment to consult with a healthcare provider to determine if it is the right option for their specific needs and health goals

The prevalence of peripheral neuropathy among the patients with diabetes in Pakistan: a systematic review and meta-analysis

Adding semaglutide to tirzepatide would, in theory, increase total GLP-1 receptor occupancy without adding meaningful GIP activationpotentially increasing side effects without proportional clinical benefit

Wegovy: started at 0.25 mg weekly and escalated every 4 weeks up to 1.7 mg or 2.4 mg weekly maintenance (2.4 mg is the recommended maintenance dose for most indications on the label) (FDA Wegovy label, 2025)